You searched for "phakic"
Impact of Eye Health Surveys and Partnerships in The Gambia
4 October 2023
| Hannah Faal, Abba Hydara, Islay Mactaggart, Matthew Burton, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
This article brings together the three national eye health surveys that have been undertaken in The Gambia between 1986 and 2019 and the impact that the results have had nationally and internationally. In it we describe the long-term capacity-strengthening for...
Meeting the needs of older patients in optics
1 February 2019
| Fiona Anderson
|
EYE - Cataract, EYE - Refractive, EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - General
Fiona Anderson discusses the important role of community-based eyecare practitioners in meeting the visual needs of ageing patients. It has been well documented that today we live for longer. Statistics show in 1997, around one in every six people (15.9%)...
The approach to trabeculectomy postoperative complications
1 August 2016
| Kaivon Pakzad-Vaezi
|
EYE - Glaucoma
Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...
Ocular bubbly: a vitreoretinal update on the art of gases
5 April 2022
| Adonis El Salloukh, Alexander Chiu, Sidath Wijetilleka
|
EYE - Vitreo-Retinal, EYE - General
The authors remind us of the revolutionary impact gases have had on retinal surgery. In 1938, Rosengren attempted to improve his retina repair surgical outcomes [1]. He discovered that suturing the retina or pressing externally on the sclera were not...
Poppers retinopathy: What is it and how do we treat it?
2 June 2025
| Alexander Benson
|
EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...
Brave new world
3 June 2024
| Peter Cackett, David Lockington
It’s a great honour to be handed the editorial relay baton by Professor Bal Dhillon and I hope I don’t fumble it along the way. As I put pen to paper, I reflect on Bal’s signing off in the last...
The role of inflammation in the pathophysiology of DMO
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...
NICE drugs: an update on what’s good to go
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...Treatment of diabetic macular oedema
1 June 2014
| Samantha S Mann
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...
Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...Pathological myopia: a trainer’s perceptive
3 April 2024
| Anitha Priya Arun Shankar, Adelehin Ijasan
|
EYE - Vitreo-Retinal
High myopia is defined as myopic refraction of greater than -6 dioptres with an axial length greater than 26.5mm, while pathological myopia is myopic refraction with posterior pole degeneration [1]. These degenerative changes can affect a young population and in...
Warfarin Induced Suprachoroidal Haemorrhage Presenting as Acute Angle Closure Glaucoma
1 February 2014
| Shampa Gupta, Kashif Ali
Spontaneous suprachoroidal haemorrhage is a rare but recognised entity. Anticoagulant therapy is a well known risk factor. We describe a case of warfarin induced suprachoroidal haemorrhage presenting as acute angle closure glaucoma in a patient with raised International Normalised Ratio...
